Accretive Health (AH) Misses Q2 EPS by 5c; Slashes FY12 EPS Outlook
Tweet Send to a Friend
Accretive Health (NYSE: AH) reported Q2 EPS of $0.03, $0.05 worse than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
